GenDx
Loes van de Pasch is Director Program Manager at GenDx. She has completed her PhD in the field of genomics and systems biology at the dept. of Molecular Cancer Research at the University of Utrecht in The Netherlands. Here, her interest in cutting-edge molecular technologies started, which she continued in 2013 when joining GenDx. She is specialized in the development of IVD products for molecular transplant diagnostics. She has contributed to the development of multiple in vitro diagnostic (IVD) products, including NGSgo® assays and NGSengine® software for high-resolution NGS-based HLA typing. In her current role as Director Program Manager, she integrates new sequencing technologies to drive innovation and enhance precision for HLA typing methodologies and chimerism monitoring, while also researching other gene systems such as KIR, LILR/LAIR, blood groups, and non-human MHC.